Hardeep Singh Tuli,
Hardeep Singh Tuli,
MSc., PhD., Asstt. Professor, M.M. University, Mullana,
Verified email at mmumullana.org
Title
Cited by
Cited by
Year
Cordycepin: a bioactive metabolite with therapeutic potential
HS Tuli, AK Sharma, SS Sandhu, D Kashyap
Life sciences 93 (23), 863-869, 2013
2292013
Ursolic acid (UA): A metabolite with promising therapeutic potential
D Kashyap, HS Tuli, AK Sharma
Life sciences 146, 201-213, 2016
2202016
Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements
V Aggarwal, HS Tuli, A Varol, F Thakral, MB Yerer, K Sak, M Varol, A Jain, ...
Biomolecules 9 (11), 735, 2019
1882019
Microbial pigments as natural color sources: current trends and future perspectives
HS Tuli, P Chaudhary, V Beniwal, AK Sharma
Journal of food science and technology 52 (8), 4669-4678, 2015
1712015
Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin
HS Tuli, SS Sandhu, AK Sharma
3 Biotech 4 (1), 1-12, 2014
1462014
Kaempferol–A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements
D Kashyap, A Sharma, HS Tuli, K Sak, S Punia, TK Mukherjee
Journal of functional foods 30, 203-219, 2017
952017
Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives
G Kumar, S Mittal, K Sak, HS Tuli
Life sciences 148, 313-328, 2016
952016
Molecular mechanisms of action of quercetin in cancer: recent advances
D Kashyap, S Mittal, K Sak, P Singhal, HS Tuli
Tumor Biology 37 (10), 12927-12939, 2016
822016
Ursolic acid and oleanolic acid: pentacyclic terpenoids with promising anti-inflammatory activities
D Kashyap, A Sharma, H S Tuli, S Punia, A K Sharma
Recent patents on inflammation & allergy drug discovery 10 (1), 21-33, 2016
802016
Isothiocyanates: a class of bioactive metabolites with chemopreventive potential
G Kumar, HS Tuli, S Mittal, JK Shandilya, A Tiwari, SS Sandhu
Tumor Biology 36 (6), 4005-4016, 2015
702015
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
D Kashyap, HS Tuli, MB Yerer, A Sharma, K Sak, S Srivastava, A Pandey, ...
Seminars in cancer biology, 2019
662019
Molecular targets of celastrol in cancer: Recent trends and advancements
D Kashyap, A Sharma, HS Tuli, K Sak, T Mukherjee, A Bishayee
Critical reviews in oncology/hematology 128, 70-81, 2018
602018
Molecular mechanisms of action of genistein in cancer: Recent advances
HS Tuli, MJ Tuorkey, F Thakral, K Sak, M Kumar, AK Sharma, U Sharma, ...
Frontiers in pharmacology 10, 1336, 2019
582019
Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy
D Kashyap, A Sharma, K Sak, HS Tuli, HS Buttar, A Bishayee
Life sciences 194, 75-87, 2018
582018
Molecular targets of gambogic acid in cancer: recent trends and advancements
D Kashyap, R Mondal, HS Tuli, G Kumar, AK Sharma
Tumor Biology 37 (10), 12915-12925, 2016
582016
Fisetin and quercetin: promising flavonoids with chemopreventive potential
D Kashyap, VK Garg, HS Tuli, MB Yerer, K Sak, AK Sharma, M Kumar, ...
Biomolecules 9 (5), 174, 2019
572019
Therapeutic charm of quercetin and its derivatives: a review of research and patents
A Sharma, D Kashyap, K Sak, HS Tuli, AK Sharma
Pharmaceutical patent analyst 7 (1), 15-32, 2018
572018
Molecular aspects of melatonin (MLT)-mediated therapeutic effects
HS Tuli, D Kashyap, AK Sharma, SS Sandhu
Life sciences 135, 147-157, 2015
542015
Molecular aspects of metal oxide nanoparticle (MO-NPs) mediated pharmacological effects
HS Tuli, D Kashyap, SK Bedi, P Kumar, G Kumar, SS Sandhu
Life sciences 143, 71-79, 2015
522015
Mechanistic insight into carnosol-mediated pharmacological effects: Recent trends and advancements
D Kashyap, G Kumar, A Sharma, K Sak, HS Tuli, TK Mukherjee
Life sciences 169, 27-36, 2017
392017
The system can't perform the operation now. Try again later.
Articles 1–20